Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

BACKGROUND: Limited information exists regarding tumor response to palbociclib plus an aromatase inhibitor (AI) versus AI alone in real-world practice. OBJECTIVE: To evaluate the real-world tumor response of palbociclib plus letrozole (PAL+LET) versus LET alone as first-line treatment for patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Brufsky, Adam, Liu, Xianchen, Li, Benjamin, McRoy, Lynn, Layman, Rachel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484164/
https://www.ncbi.nlm.nih.gov/pubmed/34338965
http://dx.doi.org/10.1007/s11523-021-00826-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484164/
https://www.ncbi.nlm.nih.gov/pubmed/34338965
http://dx.doi.org/10.1007/s11523-021-00826-1

Ejemplares similares